Завершено
Фаза III
Россия
Hydroxyprogesterone Caproate Injection (HPC), 250mg/mL; Vehicle · AMAG Pharmaceuticals, Inc.
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate (HPC) Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery